Dear dr please advise my parents that this product is good for my father I have included studies done and experts in this area I feel show a possibility it could help him, I also object to my father being giving only sedating type medications, he has always been active and alert and he should be respected if he is suffering with the appropriate and compassionate medications to help him feel alert and able to function, the so called sleeping pills are tome a terrible thing to be taking while struggling with this condition.http://dixiebotanicals.com/products/dew-drops-hemp-oil-supplement/
http://www.ncbi.nlm.nih.gov/pubmed/22849856 "
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms. [Br J Pharmacol. 2013]"http://www.ncbi.nlm.nih.gov/pubmed/22624859 "
"This study reveals that CBD inhibits angiogenesis by multiple mechanisms. Its dual effect on both tumour and endothelial cells supports the hypothesis that CBD has potential as an effective agent in cancer therapy."http://www.ncbi.nlm.nih.gov/pubmed/22506672
"Over the past years, several lines of evidence support an antitumourigenic effect of cannabinoids including Δ(9)-tetrahydrocannabinol (Δ(9)-THC), synthetic agonists, endocannabinoids and endocannabinoid transport or degradation inhibitors. Indeed, cannabinoids possess anti-proliferative and pro-apoptotic effects and they are known to interfere with tumour neovascularization, cancer cell migration, adhesion, invasion and metastasization."
http://www.ncbi.nlm.nih.gov/pubmed/22849856 "
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms. [Br J Pharmacol. 2013]"http://www.ncbi.nlm.nih.gov/pubmed/22624859 "
"This study reveals that CBD inhibits angiogenesis by multiple mechanisms. Its dual effect on both tumour and endothelial cells supports the hypothesis that CBD has potential as an effective agent in cancer therapy."http://www.ncbi.nlm.nih.gov/pubmed/22506672
"Over the past years, several lines of evidence support an antitumourigenic effect of cannabinoids including Δ(9)-tetrahydrocannabinol (Δ(9)-THC), synthetic agonists, endocannabinoids and endocannabinoid transport or degradation inhibitors. Indeed, cannabinoids possess anti-proliferative and pro-apoptotic effects and they are known to interfere with tumour neovascularization, cancer cell migration, adhesion, invasion and metastasization."
my email is williamrussellmorley@verizon.net
Neuropharmacology. 2008 Jan;54(1):244-9. Epub 2007 Jul 17.
Cannabidiol arrests onset of autoimmune diabetes in NOD mice.Weiss L, Zeira M, Reich S, Slavin S, Raz I, Mechoulam R, Gallily R.
SourceDepartment of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Hebrew University Hospital, Jerusalem 91120, Israel. lolaw@hadassa.org.il
AbstractWe have previously reported that cannabidiol (CBD) lowers the incidence of diabetes in young non-obese diabetes-prone (NOD) female mice. In the present study we show that administration of CBD to 11-14 week old female NOD mice, which are either in a latent diabetes stage or with initial symptoms of diabetes, ameliorates the manifestations of the disease. Diabetes was diagnosed in only 32% of the mice in the CBD-treated group, compared to 86% and 100% in the emulsifier-treated and untreated groups, respectively. In addition, the level of the proinflammatory cytokine IL-12 produced by splenocytes was significantly reduced, whereas the level of the anti-inflammatory IL-10 was significantly elevated following CBD-treatment. Histological examination of the pancreata of CBD-treated mice revealed more intact islets than in the controls. Our data strengthen our previous assumption that CBD, known to be safe in man, can possibly be used as a therapeutic agent for treatment of type 1 diabetes.
PMID: 17714746 [PubMed - indexed for MEDLINE] PMCID: PMC2270485 Free PMC Article
Images from this publication.See all images (2) Free text
The following toggler user interface control may not be accessible. Tab to the next button to revert the control to an accessible version.
Destroy user interface controlPublication Types, MeSH Terms, Substances, Grant Support
